Results 11 to 20 of about 187,553 (368)
Asian Journal of Andrology, 2020 Hypoxia-induced erythropoietin signaling plays an important role in tumor growth and invasion. In the present study, we investigated the contribution of erythropoietin signaling pathway to castration-resistant prostate cancer and the development of a ...
Chen Ye +5 more
doaj +1 more source
A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants.
New England Journal of Medicine, 2020 BACKGROUND High-dose erythropoietin has been shown to have a neuroprotective effect in preclinical models of neonatal brain injury, and phase 2 trials have suggested possible efficacy; however, the benefits and safety of this therapy in extremely preterm
Sandra E. Juul +27 more
semanticscholar +1 more source
Journal of Rawalpindi Medical College, 2021 Objective Of the Study: To compare efficacy of “Oral ascorbic acid in combination with Erythropoietin” with “standard dose of erythropoietin alone” in renal anemia in terms of mean hemoglobin rise.
Mansoor Abbas Qaiser +5 more
doaj +1 more source
The Many Facets of Erythropoietin Physiologic and Metabolic Response
Frontiers in Physiology, 2020 In mammals, erythropoietin (EPO), produced in the kidney, is essential for bone marrow erythropoiesis, and hypoxia induction of EPO production provides for the important erythropoietic response to ischemic stress, such as during blood loss and at high ...
S. Suresh, P. K. Rajvanshi, C. Noguchi
semanticscholar +1 more source
Haemoglobin mass and running time trial performance after recombinant human erythropoietin administration in trained men [PDF]
, 2013 <p>Recombinant human erythropoietin (rHuEpo) increases haemoglobin mass (Hbmass) and maximal oxygen uptake (v˙ O2 max).</p> <p>Purpose: This study defined the time course of changes in Hbmass, v˙ O2 max as well as running time trial ...
A Lucia +51 more
core +7 more sources
Hematology, Transfusion and Cell Therapy, 2022 Preoperative anemia is a common finding. Preoperative allogeneic transfusion, iron therapy, vitamin supplementation and erythropoietin therapy are the current management strategies for preoperative anemia.
Sheikh Muhammad Ebad Ali +5 more
doaj +1 more source
Serum Erythropoietin in Patients with Chronic Renal Failure in the Predialysis Stage [PDF]
Journal of Biomedical & Clinical Research, 2023 A prospective study was carried out of serum erythropoietin levels in patients with chronic renal failure/chronic kidney disease in the predialysis period. The study is part of scientific project № 2/2022, financed by Medical University-Pleven.
Adelaida Ruseva +5 more
doaj +3 more sources
Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal disease. [PDF]
PLoS ONE, 2010 Erythropoietin is a growth factor commonly used to manage anemia in patients with chronic kidney disease. A significant clinical challenge is relative resistance to erythropoietin, which leads to use of successively higher erythropoietin doses, failure ...
Eliyahu V Khankin +5 more
doaj +1 more source
Bench-to-bedside review: Erythropoietin and its derivatives as therapies in critical care [PDF]
, 2012 Author can archive publisher's pdf. Free via Creative Commons: CC-BENCHTOBEDSIDE-2.0.
Nandra, KK, Patel, NSA, Thiemermann, C
core +1 more source
Pharmacokinetics of recombinant human erythropoietin applied subcutaneously to children with chronic renal failure [PDF]
, 1993 The single-dose pharmacokinetics of recombinant human erythropoietin (rHuEPO) given SC was investigated in 20 patients aged 7-20 years at different stages of chronic renal failure.
Braun, A. +5 more
core +1 more source